SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-003628
Filing Date
2014-08-13
Accepted
2014-08-13 17:22:34
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q abio-10q_20140630.htm 10-Q 1150201
2 EX-10.1 abio-ex101_20140630225.htm EX-10.1 32277
3 EX-31.1 abio-ex311_20140630137.htm EX-31.1 8170
4 EX-31.2 abio-ex312_20140630136.htm EX-31.2 8133
5 EX-32.1 abio-ex321_20140630135.htm EX-32.1 11078
  Complete submission text file 0001564590-14-003628.txt   4559683

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT abio-20140630.xml EX-101.INS 564257
7 XBRL TAXONOMY EXTENSION SCHEMA abio-20140630.xsd EX-101.SCH 33753
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20140630_cal.xml EX-101.CAL 27925
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20140630_def.xml EX-101.DEF 190384
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20140630_lab.xml EX-101.LAB 264667
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20140630_pre.xml EX-101.PRE 224367
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 141038549
SIC: 2835 In Vitro & In Vivo Diagnostic Substances